Giles Wilson to take on CFO role at Dr. Martens later than expected

Dr. Martens has announced that Giles Wilson, who was appointed to the role of Chief Financial Officer in November 2023, will step into his new role on 27 May 2024.

In a statement, the company also confirmed that Giles and Katie Wilson, a person "closely associated with him", has purchased a total of 57,400 shares in Dr. Martens plc on the open market since his appointment was first announced.

He Dr. Martens from William Grant & Sons Limited, one of the largest global spirits companies which own premium brands including Glenfiddich Scotch Whisky, The Balvenie Whisky and Hendrick’s Gin. Prior to this, Wilson was the CFO at John Menzies plc, later stepping into the role of CEO.

At the time of his appointment, Giles Wilson said: "Dr. Martens is an iconic brand I have long admired, and I have been impressed by the passion and ambition within the business. I am excited to be joining at such an important stage in the Company’s growth and I am looking forward to working with Kenny and the team to drive the strategy forward."

Paul Mason, Chair of Dr. Martens, added: "Following a rigorous selection process, we are delighted to appoint Giles as CFO. He is a very capable finance leader with extensive experience in a number of sectors, and, most recently, his time in the branded spirits industry has given him a good grounding in global brands and wholesale distribution management.

"His knowledge of the public markets will be a valuable asset to the team as Dr. Martens continues its growth in the listed environment. I look forward to him joining the Board."